INS and metabolic disease: Our results confirm that OLZ impairs INS-induced glucose uptake in skeletal muscle and produces lipid accumulation in HepG2 cells, suggesting a metabolic disorder in L6 and HepG2 cell lines, which can be corrected only in liver cells but not in muscle cells.